WilmerHale Represents Nuvalent in Public Offering

WilmerHale Represents Nuvalent in Public Offering

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
On October 19, 2023, Nuvalent, Inc., a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, announced the closing of its underwritten public offering of 5,357,143 shares of its Class A common stock, at a price to the public of $56.00 per share. The aggregate gross proceeds to Nuvalent were $281.6 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Nuvalent. J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Sandler & Co. and BMO Capital Markets Corp. acted as joint book-running managers for the offering. Wedbush Securities Inc. acted as a manager for the offering.

The WilmerHale team advising Nuvalent in its public offering was led by Cynthia Mazareas, Andrea Sorrentino, Katharine Patterson, Matt Kosior and AJ Febles, with assistance from Julie Hogan Rogers, Bruce Manheim, Ben Lobley, Heidi Treiber and Senior Paralegal Mark Devine.
 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel